| PE06.06 | Covid-19 non-pharmacological public health response: Adapting virtual support to optimize peer (Thetha Nami) delivery of HIV prevention and care to adolescents and young adults in rural KwaZulu-Natal | E-poster | Contraception, pregnancy and HIV prevention (incl. PMTCT) |
| PE06.07 | Is long-acting reversible contraceptive method use associated with decreased HIV testing frequency in KwaZulu-Natal, South Africa and Lusaka, Zambia? | E-poster | Contraception, pregnancy and HIV prevention (incl. PMTCT) |
| PE06.08 | A functional performance and acceptability study of the Wondaleaf female condom | E-poster | Contraception, pregnancy and HIV prevention (incl. PMTCT) |
| PE06.10 | Integration of oral PrEP and family planning in Kenya and Zimbabwe: assessment of HIV prevention and sexual and reproductive health services to strengthen access for adolescent girls and young women | E-poster | Contraception, pregnancy and HIV prevention (incl. PMTCT) |
| PU06.02 | Post-randomization differences in condomless vaginal sex among women randomized to DMPA-IM, copper IUD and levonorgestrel implant in the ECHO trial | Publication Only | Contraception, pregnancy and HIV prevention (incl. PMTCT) |
| OA09.04 | Applying insights from HIV to guide the development of a T-cell vaccine for SARS-CoV-2 | Oral Abstract Session | COVID research: Applying lessons from HIV prevention to SARS CoV-2 |
| OA16.03 | Comparing Applicator vs. “As Lubricant” Delivery of Rectal Dapivirine Gel (MTN-033) | Oral Abstract Session | COVID research: Applying lessons from HIV prevention to SARS CoV-2 |
| PE07.01 | COVID-19 and associated disruptions may indirectly affect HIV outcomes in two capital cities in Western/Central Africa: a modelling study | E-poster | COVID research: Applying lessons from HIV prevention to SARS CoV-2 |
| PE07.02 | The impact of the COVID-19 pandemic on substance use and access to HIV prevention in Ukraine | E-poster | COVID research: Applying lessons from HIV prevention to SARS CoV-2 |
| PE07.03 | In silico down-selection of T and B cell SARS-CoV-2 epitopes for improved dendritic cells targeting vaccine platform | E-poster | COVID research: Applying lessons from HIV prevention to SARS CoV-2 |